Assenagon Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $580K | Sell |
|
|||||
|
2022
Q3 | $1.87M | Sell |
|
|||||
|
2022
Q2 | $4.16M | Sell |
|
|||||
|
2022
Q1 | $9.94M | Buy |
|
|||||
|
2021
Q4 | $1.78M | Sell |
|
|||||
|
2021
Q3 | $1.58M | Sell |
|
|||||
|
2021
Q2 | $4.64M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1.03M | Sell |
|
|||||
|
2019
Q1 | $1.72M | Buy |
|
|||||
|
2018
Q4 | $162K | Buy |
|